Committee Composition

  Audit Compensation and Management Development Nominating and Corporate Governance
Lewis T. "Rusty" Williams, M.D., Ph.D. Chairman of the Board      
Franklin M. Berger, CFA Committee Chair for Audit Committee   Member of Nominating and Corporate Governance Committee

Mr. Berger has served as a member of our board of directors since September 2010. Mr. Berger is a consultant to biotechnology industry participants, including major biopharmaceutical firms, mid-capitalization biotechnology companies, specialist asset managers and venture capital companies, providing business development, strategic advisory, financing, partnering, and royalty acquisition advice. Mr. Berger is also a biotechnology industry analyst with over 25 years of experience in capital markets and financial analysis. Mr. Berger worked at Sectoral Asset Management as a founder of the small-cap focused NEMO Fund from 2007 through June 2008. From May 1998 to March 2003, he served at J.P. Morgan Securities, most recently as Managing Director, Equity Research and Senior Biotechnology Analyst. Previously, Mr. Berger served in similar capacities at Salomon Smith Barney and Josephthal & Co. Mr. Berger also serves on the boards of directors of BELLUS Health, Inc., Immune Design Corp., ESSA Pharma Inc., and Proteostasis Therapeutics, Inc., each of which is a public biotechnology company. Mr. Berger previously served as a member of the board of directors of BioTime, Inc. and Seattle Genetics, Inc., each of which was a public company during Mr. Berger’s service as a director. Mr. Berger received a B.A. in International Relations and an M.A. in International Economics both from Johns Hopkins University and an M.B.A. from the Harvard Business School.


Garry Nicholson Member of Audit Committee    
Sheila Gujrathi, M.D.   Committee Chair for Compensation and Management Development Committee  
Peder K. Jensen, M.D.   Member of Compensation and Management Development Committee Committee Chair for Nominating and Corporate Governance Committee
Mark D. McDade   Member of Compensation and Management Development Committee  
William R. Ringo Member of Audit Committee   Member of Nominating and Corporate Governance Committee
Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member

FPRX (Common Stock)

Exchange
NASDAQ
Price
45.99
Change (%)
-0.64
Volume
343,984

Data as of 3:53 PM ET on Wednesday, October 18, 2017
Minimum 20 minute delay
Refresh quote
Powered By eSignal, Inc.